Cinryze.com
Visit cinryze.comCINRYZE® (C1 esterase inhibitor [human]) for Hereditary Angioedema
| Global rank | - |
|---|---|
| Daily visitors | - |
| Daily pageviews | - |
| Pageviews per user | 0 |
| Rating | |
|---|---|
| Status | Online |
| Latest check |
Countable Data Brief
Cinryze.com is tracked by us since February, 2018. Over the time it has been ranked as high as 820 007 in the world, while most of its traffic comes from USA, where it reached as high as 307 408 position. It was owned by several entities, from Not Disclosed of NOT DISCLOSED to Domain Admin of Takeda Pharmaceutical Company Limited, it was hosted by CERFnet and Amazon.com Inc.. While Ascio Technologies Inc. Danmark - Filial af Ascio technologies Inc. USA was its first registrar, now it is moved to CSC Corporate Domains Inc..
Cinryze has the lowest Google pagerank and bad results in terms of Yandex topical citation index. We found that Cinryze.com is poorly ‘socialized’ in respect to any social network. According to Google safe browsing analytics, Cinryze.com is quite a safe domain with no visitor reviews.
Worldwide Audience
Compare it to ...Cinryze.com gets 100% of its traffic from USA where it is ranked #307408.
Top Countries
| USA | 100.0% |
Top Ranks
| USA | 307 408 |
Traffic Analysis
Compare it to ...It seems that the number of visitors and pageviews on this site is too low to be displayed, sorry.
Pageviews
Subdomains Traffic Shares
Cinryze.com has no subdomains with considerable traffic.
SEO Stats
Compare it to ...Cinryze.com is not yet effective in its SEO tactics: it has Google PR 0. It may also be penalized or lacking valuable inbound links.
Homepage Top Backlinks PR
| firazyr.com | 0 |
| kalbitor.com | 0 |
Top Keywords % of search traffic
| cinryze | 52.18% |
| cinryze manufacturer | 4.66% |
| cinryze pediatric | 0.91% |
Domain Registration Data
Compare it to ...Cinryze.com domain is owned by Domain Admin Takeda Pharmaceutical Company Limited and its registration expires in 2 months.
General Get more Cinryze.com whois history
|
Domain Admin Takeda Pharmaceutical Company Limited Owner since February 24, 2021 |
||
|---|---|---|
|
2 months ago Expired on April 03, 2024 |
17 years old Created on April 03, 2007 |
1 year ago Changed at March 30, 2023 |
Registrar and Status
| Registar | CSC CORPORATE DOMAINS, INC. |
| Status |
clientTransferProhibited |
In Other TLDs
No data
Server Information
Compare it to ...Cinryze.com is hosted by Amazon.com, Inc.
IP Whois Get more Cinryze.com server history
-
Amazon.com, Inc.
-
13.32.151.12
IP address
Server Technologies
-
Internet Information Services
Backend server
DNS Records
Nameservers
- ns-1091.awsdns-08.org
- ns-1610.awsdns-09.co.uk
- ns-202.awsdns-25.com
- ns-872.awsdns-45.net
| host | value | ttl |
|---|---|---|
| cinryze.com | 13.32.151.15 |
60 |
| cinryze.com | 13.32.151.12 |
60 |
| cinryze.com | 13.32.151.47 |
60 |
| cinryze.com | 13.32.151.40 |
60 |
| host | value | ttl | pri |
|---|---|---|---|
| cinryze.com | postmaster.imc2.com |
3600 | 10 |
| host | value | ttl |
|---|---|---|
| cinryze.com | ns-1091.awsdns-08.org |
86400 |
| cinryze.com | ns-1610.awsdns-09.co.uk |
86400 |
| cinryze.com | ns-202.awsdns-25.com |
86400 |
| cinryze.com | ns-872.awsdns-45.net |
86400 |
| host | value | ttl |
|---|---|---|
| cinryze.com | Mname: ns-872.awsdns-45.net |
900 |
| host | value | ttl |
|---|---|---|
| cinryze.com | Txt: v=spf1 a mx include:_spf.elasticemail.com include:spf.tkda.techspa.com ~all |
3600 |
| cinryze.com | Txt: viq257ecibt0siq3l8filrmb1h |
3600 |
| cinryze.com | Txt: 1VQBiWH |
3600 |
Safety
Compare it to ...Safety status of Cinryze.com is described as follows: Google Safe Browsing reports its status as safe.
Get more Cinryze.com reviews
MyWOT
| Overall reputation | Unknown |
|---|---|
| Trustworthiness | Unknown |
| Privacy | Unknown |
| Child safety | Unknown |
Google Safe Browsing
| Website status | Safe |
|---|---|
| Status | ok |
User reviews
| Reputation | Unknown | |
|---|---|---|
|
0 positive0 negative |
||
Social Engagement
Compare it to ...It seems Cinryze.com has no mentions in social networks.